1 / 3

Antidiabetics Market Size

The Global Antidiabetics Market estimated at USD 63.5 billion in 2019, is expected to reach USD 121.40 Billion in 2026, at a CAGR of 9.70 % during the projection period.

priyanka25avhad
Download Presentation

Antidiabetics Market Size

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Global Antidiabetics Market

  2. According to BlueWeave Consulting, The Global Antidiabetics Market was valued at USD 63.5 billion in 2019 and is expected to reach USD 121.40 billion in 2026, at a CAGR of 9.7% during the forecast period. The increasing risk of diabetes across all age-group worldwide, need for medicatiion without substantial side effects and increasing R & D outlays of the pharmaceutical companies drive the growth of this market. The complete treatment for diabetes has become the focal point of care due to the burgeoning diabetic population across all age-groups including children. The anti-diabetics market has developed immensely in recent years due to growing occurrence of diabetes mellitus and, is expected to expand substantially due to its mounting demand and acceptance in emerging and advanced nations during the forecast period.  Diabetes is a chronic metabolic disease wherein the body is either unable to produce insulin (Type-1) or cannot absorb the manufactured insulin (Type-2). The diabetic individual suffers from high blood glucose (blood sugar) and experience symptoms such as grown thirst (polydipsia), weight loss, increased hunger (polyphagia), and recurrent and sweet-smelling urination (polyuria).

  3. The AntiDiabetic Market is segmented based on Product, Administration Route, Patient Age-group and into Insulin segment and Drug segment based on product. Based on Product, the market is subdivided into Insulin Products and Drugs while based on Route of Administration, it is divided into Syringe/Pen, Insulin Pump, Intravenous Infusion and Oral. "The Insulin Products segment and Insulin-Pump segment hold the major market share." The Insulin Product segment leads the antidiabetic market, followed by Drug segment. It secured a notable market share in 2019 and, is anticipated to continue the same at a remarkable CAGR of 12.4% during the forthcoming period due to its high success rate. Besides, short-acting analog in this segment has improved glucose-controlling ability in Type 1 and Type 2 diabetes. The segment is expected to witness unparalleled growth due to surge in diabetes-2 patients.Get the Sample Copy of the Report:https://www.blueweaveconsulting.com/global-antidiabetics-market-bwc20130/report-sample

More Related